Diagnostic Imaging’s Weekly Scan: January 4 — January 10

Welcome to Diagnostic Imaging’s Weekly Scan, which offers an opportunity to catch up on the most well-viewed radiology content of the past week.

New prospective research published in the European Journal of Radiology revealed that the use of contrast-enhanced mammography in nearly 200 cases of screening recalls yielded a 96.1 percent per-breast sensitivity rate and a 99 percent negative predictive value.

In a recent interview with Diagnostic Imaging, Onofrio Catalano, M.D., Ph.D., discussed new research findings demonstrating robust sensitivity and specificity with PET/MRI in detecting hepatocellular carcinoma in patients with LI-RADS 3 presentations and cirrhosis.

In another interview with Diagnostic Imaging, Jeremie Calais, M.D., discussed new research examining the prognostic capacity of PSMA PET parameters in predicting hematologic toxicity and outcomes for patients treated with Pluvicto for mCRPC.

For patients with triple-negative breast cancer being treated with neoadjuvant chemotherapy and immunotherapy, new research in European Radiology showed that MRI offered a 94.3 percent sensitivity for predicting pathologic complete response.

We also saw new research in the Radiology journal examining the utility of large language models (LLMs). In a study involving over 1,400 patients who had abdominal or pelvic CTs, the GPT-4o LLM selected optimal protocols in 96.2 percent of cases in comparison to 88.3 percent for radiologists.

Watch the video summary below of Diagnostic Imaging’s Weekly Scan.